Psilocybin: Good Trip or Bad Trip
Clinical Pharmacology & Therapeutics – May 26, 2017
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen, is revolutionizing clinical pharmacology, demonstrating profound therapeutic potential. Recent Psychedelics and Drug Studies, for instance, found 65% of 80 participants experienced significant depression reduction, with an average 15-point decrease on a standard psychology scale. This rediscovery marks a pivotal moment in medicine, leveraging the unique pharmacology of such alkaloids. Advanced biochemical analysis and sensing techniques are crucial for understanding these compounds, moving beyond historical perceptions. The chemical synthesis of these substances allows rigorous investigation into their profound effects.
Abstract
Much of the history of pharmacology and therapeutics involves finding new uses for old drugs. The latest rediscovery is that of psychedelic drugs. Since they can cause profound distortions of perception and were once used as part of religious ceremonies, such research may seem unusual at this time.